Deborah Donnell
#117,651
Most Influential Person Now
New Zealand and American biostatistician
Deborah Donnell's AcademicInfluence.com Rankings
Deborah Donnellmathematics Degrees
Mathematics
#7922
World Rank
#10767
Historical Rank
Statistics
#1059
World Rank
#1162
Historical Rank
Measure Theory
#3274
World Rank
#3870
Historical Rank
Download Badge
Mathematics
Deborah Donnell's Degrees
- PhD Biostatistics University of Auckland
- Masters Statistics University of New Zealand
Why Is Deborah Donnell Influential?
(Suggest an Edit or Addition)According to Wikipedia, Deborah J. Donnell is a New Zealand and American biostatistician known for her research on the prevention of HIV infection. She is a professor in the Vaccine and Infectious Disease Division and Public Health Sciences Division of the Fred Hutchinson Cancer Research Center, and an affiliate professor of global health and health services at the University of Washington.
Deborah Donnell's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. (2012) (2748)
- Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis (2010) (982)
- Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. (2012) (436)
- Bacterial Vaginosis Associated with Increased Risk of Female-to-Male HIV-1 Transmission: A Prospective Cohort Analysis among African Couples (2012) (327)
- Genital HIV-1 RNA Predicts Risk of Heterosexual HIV-1 Transmission (2011) (294)
- HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention (2014) (284)
- Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples (2011) (267)
- Childhood Sexual Abuse Is Highly Associated With HIV Risk-Taking Behavior and Infection Among MSM in the EXPLORE Study (2009) (245)
- Adherence to Antiretroviral Prophylaxis for HIV Prevention: A Substudy Cohort within a Clinical Trial of Serodiscordant Couples in East Africa (2013) (203)
- HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial (2019) (199)
- Estimating the Impact of Plasma HIV-1 RNA Reductions on Heterosexual HIV-1 Transmission Risk (2010) (189)
- Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART). (2019) (185)
- Coreceptor Tropism in Human Immunodeficiency Virus Type 1 Subtype D: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations (2007) (183)
- The Effect of Psychosocial Syndemic Production on 4-Year HIV Incidence and Risk Behavior in a Large Cohort of Sexually Active Men Who Have Sex With Men (2015) (182)
- Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1–Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda (2016) (178)
- Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. (2021) (163)
- Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition. (2021) (148)
- Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066). (2016) (144)
- Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trial. (2014) (139)
- The efficacy of a network intervention to reduce HIV risk behaviors among drug users and risk partners in Chiang Mai, Thailand and Philadelphia, USA. (2009) (130)
- Non-injection substance use correlates with risky sex among men having sex with men: data from HIVNET. (1999) (123)
- Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial (2013) (121)
- Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial. (2014) (112)
- Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis. (2013) (112)
- HPTN 071 (PopART): A Cluster-Randomized Trial of the Population Impact of an HIV Combination Prevention Intervention Including Universal Testing and Treatment: Mathematical Model (2014) (111)
- Seroadaptive Practices: Association with HIV Acquisition among HIV-Negative Men Who Have Sex with Men (2012) (110)
- Recent Patterns in Population-Based HIV Prevalence in Swaziland (2013) (105)
- A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial (2017) (104)
- HIV incidence determination in the United States: a multiassay approach. (2013) (102)
- Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients (2017) (100)
- Risk of drug resistance among persons acquiring HIV within a randomized clinical trial of single- or dual-agent preexposure prophylaxis. (2015) (94)
- Characteristics of HIV-1 Serodiscordant Couples Enrolled in a Clinical Trial of Antiretroviral Pre-Exposure Prophylaxis for HIV-1 Prevention (2011) (92)
- Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trial. (2015) (92)
- Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial. (2014) (91)
- Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples (2010) (87)
- Serosorting Is Associated with a Decreased Risk of HIV Seroconversion in the EXPLORE Study Cohort (2010) (84)
- Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials (2017) (83)
- Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load. (2001) (81)
- Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission. (2007) (80)
- Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials (2020) (77)
- Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection. (2001) (76)
- Genomewide Association Study for Determinants of HIV-1 Acquisition and Viral Set Point in HIV-1 Serodiscordant Couples with Quantified Virus Exposure (2011) (76)
- Relationships between social norms, social network characteristics, and HIV risk behaviors in Thailand and the United States. (2009) (74)
- The dynamic relationship between social norms and behaviors: the results of an HIV prevention network intervention for injection drug users. (2013) (73)
- Swaziland HIV Incidence Measurement Survey (SHIMS): a prospective national cohort study. (2017) (71)
- Homozygous and Heterozygous CCR5‐&Dgr;32 Genotypes Are Associated With Resistance to HIV Infection (2001) (69)
- Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection (2007) (67)
- The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion (2017) (60)
- Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa. (2017) (59)
- COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact (2020) (58)
- Daily oral tenofovir and emtricitabine-tenofovir preexposure prophylaxis reduces herpes simplex virus type 2 acquisition among heterosexual HIV-1-uninfected men and women: a subgroup analysis of a randomized trial. (2014) (58)
- Impact of a universal testing and treatment intervention on HIV incidence in Zambia and South Africa: results of the HPTN 071 (PopART) community-randomized trial (2019) (56)
- Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis (2016) (56)
- Use of Non-Occupational Post-Exposure Prophylaxis does not Lead to an Increase in High Risk Sex Behaviors in Men Who have Sex with Men Participating in the EXPLORE Trial (2010) (55)
- Predictors of HIV Transmission Risk Behavior and Seroconversion Among Latino Men Who have Sex with Men in Project EXPLORE (2012) (53)
- Comparison of a High-Resolution Melting Assay to Next-Generation Sequencing for Analysis of HIV Diversity (2012) (52)
- Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial. (2020) (50)
- Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1-serodiscordant couples. (2015) (49)
- An Intervention to Support HIV Preexposure Prophylaxis Adherence in HIV-Serodiscordant Couples in Uganda (2014) (48)
- Cross-Sectional HIV Incidence Estimation in HIV Prevention Research (2013) (47)
- Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa (2017) (45)
- Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception (2014) (44)
- Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study. (2017) (43)
- Preventing HIV-1 Infection in Women using Oral Pre-Exposure Prophylaxis: A Meta-analysis of Current Evidence. (2016) (43)
- PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial (2021) (43)
- Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries. (2012) (42)
- Use of a High Resolution Melting (HRM) Assay to Compare Gag, Pol, and Env Diversity in Adults with Different Stages of HIV Infection (2011) (42)
- Outside Sexual Partnerships and Risk of HIV Acquisition for HIV Uninfected Partners in African HIV Serodiscordant Partnerships (2012) (42)
- Substance Use Among Men Who Have Sex With Men: Comparison With a National Household Survey (2001) (41)
- Predictors of Early and Late Mother-to-Child Transmission of HIV in a Breastfeeding Population: HIV Network for Prevention Trials 012 Experience, Kampala, Uganda (2009) (41)
- Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception (2014) (41)
- Hormonal contraceptive use and risk of HIV-1 disease progression (2013) (39)
- Low Risk of Proximal Tubular Dysfunction Associated With Emtricitabine-Tenofovir Disoproxil Fumarate Preexposure Prophylaxis in Men and Women. (2016) (38)
- Daily Short Message Service Surveys to Measure Sexual Behavior and Pre-exposure Prophylaxis Use Among Kenyan Men and Women (2013) (37)
- Characterization of HIV infection in cisgender men and transgender women who have sex with men receiving injectable cabotegravir for HIV prevention: HPTN 083. (2021) (37)
- HIV-1 tropism and survival in vertically infected Ugandan infants. (2008) (35)
- Substance use among men who have sex with men: comparison with a national household survey. (2001) (35)
- Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study. (2014) (34)
- Analysis of HIV diversity using a high-resolution melting assay. (2010) (33)
- A Prospective Study of the Effect of Pregnancy on CD4 Counts and Plasma HIV-1 RNA Concentrations of Antiretroviral-Naive HIV-1–Infected Women (2014) (32)
- Anal Sex Role Segregation and Versatility Among Men Who Have Sex With Men: EXPLORE Study (2013) (32)
- Development of Methods for Cross-Sectional HIV Incidence Estimation in a Large, Community Randomized Trial (2013) (32)
- Estimation of HIV Incidence in a Large, Community-Based, Randomized Clinical Trial: NIMH Project Accept (HIV Prevention Trials Network 043) (2013) (32)
- Successful Discontinuation of the Placebo Arm and Provision of an Effective HIV Prevention Product After a Positive Interim Efficacy Result: The Partners PrEP Study Experience (2014) (30)
- Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current Evidence. (2016) (30)
- PrEP Adherence Patterns Strongly Affect Individual HIV Risk and Observed Efficacy in Randomized Clinical Trials (2016) (29)
- Expanding Substance Use Treatment Options for HIV Prevention With Buprenorphine–Naloxone: HIV Prevention Trials Network 058 (2015) (29)
- Estimating efficacy in a randomized trial with product nonadherence: application of multiple methods to a trial of preexposure prophylaxis for HIV prevention. (2015) (29)
- Clinician Practices and Attitudes Regarding Early Antiretroviral Therapy in the United States (2012) (28)
- Mortality Among Injection Drug Users in Northern Thailand: A Prospective Cohort Study (2010) (27)
- Use of a risk scoring tool to identify higher-risk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention (2016) (27)
- Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis (2018) (27)
- Quantifying ongoing HIV-1 exposure in HIV-1-serodiscordant couples to identify individuals with potential host resistance to HIV-1. (2012) (25)
- Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessation (2016) (25)
- Long-Term Follow-Up of Children in the HIVNET 012 Perinatal HIV Prevention Trial: Five-Year Growth and Survival (2013) (25)
- Understanding low sensitivity of community-based HIV rapid testing: experiences from the HPTN 071 (PopART) trial in Zambia and South Africa (2017) (24)
- DMPA and HIV: why we need a trial. (2014) (24)
- Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial (2017) (23)
- Scale up of PrEP integrated in public health HIV care clinics: a protocol for a stepped-wedge cluster-randomized rollout in Kenya (2018) (23)
- Rationale and design of a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study). (2017) (22)
- Individual and community-level risk factors for HIV stigma in 21 Zambian and South African communities: analysis of data from the HPTN071 (PopART) study (2018) (22)
- Design of the HPTN 065 (TLC-Plus) study: A study to evaluate the feasibility of an enhanced test, link-to-care, plus treat approach for HIV prevention in the United States (2017) (22)
- Statistical considerations for the HPTN 052 Study to evaluate the effectiveness of early versus delayed antiretroviral strategies to prevent the sexual transmission of HIV-1 in serodiscordant couples. (2012) (22)
- Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061 (2015) (21)
- Prevalence, Magnitude, and Correlates of HIV-1 Genital Shedding in Women on Antiretroviral Therapy (2017) (20)
- Impact of mutation type and amplicon characteristics on genetic diversity measures generated using a high-resolution melting diversity assay. (2013) (20)
- Individual and community-level risk factors for HIV stigma in 21 Zambian and South African communities : analysis of data from the HPTN 071 ( PopART ) study (2019) (20)
- Detection of K103N in Ugandan women after repeated exposure to single dose nevirapine (2007) (20)
- In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine. (2009) (19)
- Protocol for a randomised controlled implementation trial of point-of-care viral load testing and task shifting: the Simplifying HIV TREAtment and Monitoring (STREAM) study (2017) (19)
- Efficacy of single-dose HPV vaccination among young African women (2021) (19)
- Association of HIV Diversity and Survival in HIV-Infected Ugandan Infants (2011) (18)
- Use of HIV Case Surveillance System to Design and Evaluate Site-Randomized Interventions in an HIV Prevention Study: HPTN 065 (2012) (18)
- Taking stock of the present and looking ahead: envisioning challenges in the design of future HIV prevention efficacy trials. (2019) (17)
- Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial (2021) (17)
- HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya (2019) (16)
- Development of parallel measures to assess HIV stigma and discrimination among people living with HIV, community members and health workers in the HPTN 071 (PopART) trial in Zambia and South Africa (2019) (16)
- Frequency of False Positive Rapid HIV Serologic Tests in African Men and Women Receiving PrEP for HIV Prevention: Implications for Programmatic Roll-Out of Biomedical Interventions (2015) (16)
- The Cost-Effectiveness of Financial Incentives for Viral Suppression: HPTN 065 Study. (2019) (16)
- Study Design Considerations for Evaluating Efficacy of Systemic Preexposure Prophylaxis Interventions (2013) (16)
- Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons. (2015) (16)
- Correlation Between Pill Counts and Biologic Effects in an HIV-1 Prevention Clinical Trial: Implications for Measuring Adherence (2013) (15)
- Experience in international clinical research: the HIV Prevention Trials Network. (2011) (15)
- Differential regulatory T cell activity in HIV type 1-exposed seronegative individuals. (2013) (15)
- HIV prevention trial design in an era of effective pre-exposure prophylaxis (2017) (15)
- Adaptive non-inferiority margins under observable non-constancy (2018) (14)
- Objective Measurement of Inaccurate Condom Use Reporting Among Women Using Depot Medroxyprogesterone Acetate for Contraception (2017) (14)
- Single-dose HPV vaccination efficacy among adolescent girls and young women in Kenya (the KEN SHE Study): study protocol for a randomized controlled trial (2021) (14)
- A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings (2021) (14)
- Are there adverse consequences of quizzing during informed consent for HIV research? (2011) (14)
- Integrating oral PrEP delivery among African women in a large HIV endpoint‐driven clinical trial (2020) (13)
- Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission (2006) (13)
- Use of a High Resolution Melting Assay to Analyze HIV Diversity in HIV-infected Ugandan Children (2012) (13)
- Assessment of Contamination and Misclassification Biases in a Randomized Controlled Trial of a Social Network Peer Education Intervention to Reduce HIV risk Behaviors Among Drug Users and Risk Partners in Philadelphia, PA and Chiang Mai, Thailand (2015) (13)
- Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 Infection (2016) (13)
- Regional differences between people who inject drugs in an HIV prevention trial integrating treatment and prevention (HPTN 074): a baseline analysis (2018) (13)
- Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials (2020) (13)
- Summary Measures of Adherence Using Pill Counts in Two HIV Prevention Trials: The Need for Standardisation in Reporting (2013) (12)
- HIV Stigma and Viral Suppression Among People Living With HIV in the Context of Universal Test and Treat: Analysis of Data From the HPTN 071 (PopART) Trial in Zambia and South Africa (2020) (12)
- HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples (2014) (12)
- HIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis (2016) (12)
- Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series study (2021) (11)
- Improvements in the HIV care continuum needed to meaningfully reduce HIV incidence among men who have sex with men in Baltimore, US: a modelling study for HPTN 078 (2019) (11)
- A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated (2021) (11)
- Pregnancy Does Not Affect HIV Incidence Test Results Obtained Using the BED Capture Enzyme Immunoassay or an Antibody Avidity Assay (2010) (11)
- In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs? (2018) (11)
- Association between HIV stigma and antiretroviral therapy adherence among adults living with HIV: baseline findings from the HPTN 071 (PopART) trial in Zambia and South Africa (2020) (10)
- Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant (2020) (10)
- Determination of HIV Status in African Adults With Discordant HIV Rapid Tests (2015) (10)
- O11.2 Sexual Behaviour of Heterosexual Men and Women Receiving Antiretroviral Pre-Exposure Prophylaxis For HIV Prevention: Post-Unblinding Analysis of the Partners PrEP Study (2013) (9)
- Antiretroviral Drug Use in a Cross-Sectional Population Survey in Africa: NIMH Project Accept (HPTN 043) (2017) (9)
- The effect of universal testing and treatment on HIV stigma in 21 communities in Zambia and South Africa (2020) (9)
- Prevalence and Seroincidence of Hepatitis B and Hepatitis C Infection in High Risk People Who Inject Drugs in China and Thailand (2014) (9)
- Fostering community understanding of sufficient benefit and early stopping for a phase 2B HIV prevention clinical trial in Africa (2011) (9)
- Analysis of HIV tropism in Ugandan infants. (2010) (9)
- Challenges in the Design of HIV Prevention Trials in the United States (2010) (8)
- Ethical considerations for new HIV prevention trials. (2019) (8)
- Analysis of HIV type 1 gp41 and enfuvirtide susceptibility among men in the United States who were HIV infected prior to availability of HIV entry inhibitors. (2009) (8)
- Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre‐exposure prophylaxis adherence among adolescent girls in the HPTN 082 randomized controlled trial (2021) (8)
- Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand. (2014) (8)
- HIV Surveillance in a Large, Community-Based Study: Results from the Pilot Study of Project Accept (HIV Prevention Trials Network 043) (2011) (8)
- High Incidence Is Not High Exposure: What Proportion of Prevention Trial Participants Are Exposed to HIV? (2015) (8)
- Rationale and design of a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study) (2017) (8)
- Hypertension in pregnancy among HIV-infected women in sub-Saharan Africa: prevalence and infant outcomes. (2009) (8)
- Understanding the HIV Epidemic Among MSM in Baltimore: A Modeling Study Estimating the Impact of Past HIV Interventions and Who Acquired and Contributed to Infections (2020) (7)
- Quantifying the contribution of different aged men and women to onwards transmission of HIV-1 in generalised epidemics in sub-Saharan Africa: A modelling and phylogenetics approach from the HPTN071 (PopART) trial (2019) (7)
- Urine Tenofovir Levels Measured Using a Novel Immunoassay Predict Human Immunodeficiency Virus Protection (2020) (6)
- Outcomes from NIMH Project Accept (HPTN 043): a cluster-randomized trial of community mobilization, mobile HIV testing, post-test support services, and real-time performance feedback (2014) (6)
- Brief Report: Durability of the Effect of Financial Incentives on HIV Viral Load Suppression and Continuity in Care: HPTN 065 Study (2018) (6)
- PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project (2022) (6)
- Determination of HIV status and identification of incident HIV infections in a large, community‐randomized trial: HPTN 071 (PopART) (2020) (6)
- Genital HIV-1 RNA Quantity Predicts Risk of Heterosexual HIV-1 Transmission (2011) (6)
- O10.3 High curable STI prevalence and incidence among young african women initiating PrEP in HPTN 082 (2019) (6)
- Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Southern Africa. (2015) (6)
- Identifying Regions of Greatest Need for Ending the HIV Epidemic: A Plan for America. (2020) (6)
- Urine Tenofovir Levels Measured Using a Novel Immunoassay Predict Human Immunodeficiency Virus Protection (2020) (6)
- How ‘place’ matters for addressing the HIV epidemic: evidence from the HPTN 071 (PopART) cluster-randomised controlled trial in Zambia and South Africa (2021) (5)
- PopART-IBM, a highly efficient stochastic individual-based simulation model of generalised HIV epidemics developed in the context of the HPTN 071 (PopART) trial (2020) (5)
- Sexual Behavior and Perceived HIV Risk Among HIV-Negative Members of Serodiscordant Couples in East Africa (2020) (5)
- Single-Agent Tenofovir versus Combination Emtricitabine/ Tenofovir for Pre-Exposure Prophylaxis against HIV-1 Acquisition: A Randomized Trial (2014) (5)
- Changing Clinician Practices and Attitudes Regarding the Use of Antiretroviral Therapy for HIV Treatment and Prevention (2017) (5)
- Validation of population‐level HIV‐1 incidence estimation by cross‐sectional incidence assays in the HPTN 071 (PopART) trial (2021) (4)
- Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial. (2021) (4)
- Recruitment of Female Sex Workers in HIV Prevention Trials: Can Efficacy Endpoints Be Reached More Efficiently? (2017) (4)
- Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trial (2022) (4)
- Positive Social Impacts Related to Participation in an HIV Prevention Trial Involving People Who Inject Drugs. (2015) (4)
- LB IMPACT OF UNIVERSAL TESTING AND TREATMENT IN ZAMBIA AND SOUTH AFRICA : HPTN 071 ( POPART ) (2019) (4)
- Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
- Herpes Simplex Virus Type 2 Acquisition Among HIV-1–Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study (2017) (4)
- Adaptive HIV pre-exposure prophylaxis adherence interventions for young South African women: Study protocol for a sequential multiple assignment randomized trial (2022) (4)
- Sample size calculation for active-arm trial with counterfactual incidence based on recency assay (2020) (4)
- Model-Based Predictions of HIV Incidence Among African Women Using HIV Risk Behaviors and Community-Level Data on Male HIV Prevalence and Viral Suppression. (2020) (4)
- Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women (2016) (4)
- Co-receptor Tropism in Subtype D HIV-1 : High Prevalence of CXCR 4 Tropism and Heterogeneous Composition of Viral Populations (2007) (4)
- Intimate partner violence and oral HIV pre-exposure prophylaxis adherence among young African women (2022) (3)
- P3.370 Daily Oral Emtricitabine/Tenofovir Pre-Exposure Prophylaxis and Prevention of HSV-2 Acquisition Among Heterosexual Men and Women (2013) (3)
- Impact of Tenofovir-Based Pre-exposure Prophylaxis on Biomarkers of Bone Formation, Bone Resorption, and Bone Mineral Metabolism in HIV-Negative Adults (2019) (3)
- Model-based predictions of HIV incidence among African women using HIV risk behaviors and community-level data on male HIV prevalence and viral suppression. (2020) (3)
- Genital microbiota of women using a 90 day tenofovir or tenofovir and levonorgestrel intravaginal ring in a placebo controlled randomized safety trial in Kenya (2022) (3)
- Current and Future Challenges in Trial Design for Pre-Exposure Prophylaxis in HIV Prevention (2019) (3)
- Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections. (2023) (3)
- Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study. (2017) (3)
- Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trial. (2022) (3)
- Ethical issues in establishing the efficacy and safety of long-acting injectable pre-exposure prophylaxis for HIV prevention: the HPTN 083 trial. (2021) (3)
- Predicted Effectiveness of Daily and Nondaily Preexposure Prophylaxis for Men Who Have Sex With Men Based on Sex and Pill-taking Patterns From the Human Immuno Virus Prevention Trials Network 067/ADAPT Study (2019) (3)
- High levels of viral suppression among East African HIV-infected women and men in serodiscordant partnerships initiating antiretroviral therapy with high CD4 counts and during pregnancy. (2018) (3)
- Community-based health workers implementing universal access to HIV testing and treatment: lessons from South Africa and Zambia—HPTN 071 (PopART) (2021) (3)
- Impact of Tenofovir-Based Pre-exposure Prophylaxis on Biomarkers of Bone Formation, Bone Resorption, and Bone Mineral Metabolism in HIV-Negative Adults (2019) (3)
- Evaluation of multi-assay algorithms for identifying individuals with recent HIV infection: HPTN 071 (PopART) (2021) (2)
- Urine Tenofovir Levels Measured by a Novel Immunoassay Predict HIV Protection. (2020) (2)
- Changing Antiretroviral Eligibility Criteria: Impact on the Number and Proportion of Adults Requiring Treatment in Swaziland (2016) (2)
- Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysis (2022) (2)
- Rates of viral suppression in a cohort of people with stable HIV from two community models of ART delivery versus facility-based HIV care in Lusaka, Zambia: a cluster-randomised, non-inferiority trial nested in the HPTN 071 (PopART) trial (2021) (2)
- Positive Social Impacts Related to Participation in an HIV Prevention Trial Involving Medication Assisted Treatment of People Who Inject Drugs (2013) (2)
- Demographic characteristics of sources of HIV-1 transmission in Zambia (2021) (2)
- Risky Sexual Behavior Among Individuals Receiving Buprenorphine/Naloxone Opiate Dependency Treatment: HIV Prevention Trials Network (HPTN) 058 (2018) (2)
- CD101 genetic variants modify regulatory and conventional T cell phenotypes and functions (2021) (2)
- Relationships between Social Norms, Social Network Characteristics, and HIV Risk Behaviors in Thailand and the U.S (2010) (1)
- Predicted effectiveness of daily and non-daily PrEP for MSM based on sex and pill-taking patterns from HPTN 067/ADAPT. (2019) (1)
- Correction: Genomewide Association Study for Determinants of HIV-1 Acquisition and Viral Set Point in HIV-1 Serodiscordant Couples with Quantified Virus Exposure (2012) (1)
- Association between rectal gonorrhoea and HIV incidence in men who have sex with men: a meta-analysis (2021) (1)
- The association between HIV stigma and HIV incidence in the context of universal testing and treatment: analysis of data from the HPTN 071 (PopART) trial in Zambia and South Africa (2022) (1)
- Track C Epidemiology and Prevention Science (2012) (1)
- Reversibility of kidney function decline in HIV-1–uninfected men and women using preexposure prophylaxis (2015) (1)
- Analysis Plan for Individual-based Model Projections of the HPTN 071 ( PopART ) Intervention (2018) (1)
- Kidney injury biomarkers during exposure to tenofovir-based pre-exposure prophylaxis. (2021) (1)
- Brief Report: Bacterial Vaginosis and Risk of HIV Infection in the Context of CD101 Gene Variation (2020) (1)
- Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2: a prespecified secondary outcomes analysis of the HPTN 071 (PopART) community-randomised trial (2022) (1)
- Pregnancy rates and clinical outcomes among women living with HIV enrolled in HPTN 052. (2022) (1)
- HIV drug resistance in a community‐randomized trial of universal testing and treatment: HPTN 071 (PopART) (2022) (1)
- Designing the Next Generation of HIV Prevention Efficacy Trials: Synopsis of a 2018 Symposium (2019) (1)
- Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa (the HPTN 071 [PopART] trial): a modelling study (2022) (1)
- PrEP uptake and HIV viral suppression when PrEP is integrated into Ugandan ART clinics for HIV-negative members of HIV-serodifferent couples: A stepped wedge cluster randomized trial (2022) (1)
- HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in US women; Postive impact of a randomized controlled trial of the Uthando Lwethu ("Our Love") intervention on rates of couples HIV testing in rural South Africa (2016) (1)
- A public health approach to addressing and preventing misdiagnosis in the scale‐up of HIV rapid testing programmes (2017) (1)
- Reducing the Global HIV Burden: The Importance of Uneven Exposure to the Results of HIV Prevention Trials (2020) (1)
- Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa (the HPTN 071 [PopART] trial): a modelling study (2022) (1)
- Designing & Conducting Trials to Reliably Evaluate HIV Prevention Interventions (2019) (1)
- High HIV incidence among young women in South Africa: Data from a large prospective study (2022) (1)
- PLOS Medicine 2017 Reviewer and Editorial Board Thank You (2018) (1)
- Novel approaches for development of HIV pre-exposure prophylaxis (PrEP) agents. (2019) (0)
- High prevalence and incidence of gonorrhoea and chlamydia in young women eligible for HIV pre-exposure prophylaxis in South Africa and Zimbabwe: results from the HPTN 082 trial (2023) (0)
- Development of a tool to assess HIV prevention readiness of adolescent girls and young women in HPTN 082 study (2023) (0)
- Estimating benefits of using on-demand oral prep by MSM: A comparative modeling study of the US and Thailand (2022) (0)
- in African HIV-1 Serodiscordant Couples (2018) (0)
- Correction for Lund et al., HIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis (2017) (0)
- Ubiquitination and segmentation of HIV genetic components: Aiming towards an HIV vaccine inducing broad(er) T cell immune responses (2008) (0)
- Intimate partner violence and early PrEP adherence among adolescent girls and young women in Cape Town, South Africa: A longitudinal analysis (2018) (0)
- Supporting Research Sites in Resource-Limited Settings: Challenges in Implementing Information Technology Infrastructure (2014) (0)
- Facilitating Next-Generation Pre-Exposure Prophylaxis Clinical Trials Using HIV Recent Infection Assays: A Consensus Statement from the Forum HIV Prevention Trial Design Project. (2022) (0)
- Antiretroviral Drug Detection in a Community-Randomized Trial of Universal HIV Testing and Treatment: HPTN 071 (PopART) (2022) (0)
- Taking stock of the present and looking to the future: Envisioning challenges in the design of future HIV prevention efficacy trials (2019) (0)
- Use a high resolution melting assay to compare and env diversity in adults with different stages of HIV infection. (2011) (0)
- TUPDC0103: Gonorrhea infections diagnosed among persons living with HIV: cross matching surveillance registries to identify potential opportunities for integrated partner services-New York City, Washington D.C., Miami/Dade County and Arizona (2012) (0)
- Choosing a metric for measurement of pre-exposure prophylaxis. (2014) (0)
- Novel Approaches for Development of Human Immunodeficiency Virus Preexposure Prophylaxis Agents (2019) (0)
- Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial (2021) (0)
- ADAPTIVE TIME LOCATION SAMPLING FOR COMPASS, A SARS-COV-2 PREVALENCE STUDY IN FIFTEEN DIVERSE COMMUNITIES IN THE UNITED STATES (2023) (0)
- P3.200 Effect of Pregnancy on HIV-1 Disease Progression Among Antiretroviral-Naive HIV-1 Infected Women (2013) (0)
- Evaluating group-sequential non-inferiority clinical trials following interim stopping: The HIV Prevention Trials Network 083 trial (2022) (0)
- Sexual Behaviors After PrEP Discontinuation Among HIV Serodiscordant Couples in Kenya and Uganda (2020) (0)
- Assessing the use of surveillance data to estimate the impact of prevention interventions on HIV incidence in cluster-randomized controlled trials (2020) (0)
- Estimating the Impact of PrEP Regimens Containing Long-Acting Injectable Cabotegravir or Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine Among Men Who Have Sex with Men in the United States: Mathematical Modelling for HPTN 083 (2022) (0)
- Uptake of medical male circumcision with household-based testing, and the association of traditional male circumcision and HIV infection (2023) (0)
- Practical issues in operationalizing the design and outcome evaluation of cluster randomized trials (2022) (0)
- Characteristics of Kenyan Women Enrolled in a Trial on Doxycycline Post-exposure Prophylaxis for Sexually Transmitted Infection Prevention (2022) (0)
- Baeten Genital HIV-1 RNA Predicts Risk of Heterosexual HIV-1 Transmission (2011) (0)
This paper list is powered by the following services:
Other Resources About Deborah Donnell
What Schools Are Affiliated With Deborah Donnell?
Deborah Donnell is affiliated with the following schools:
